PCV85 DOES A SINGLE PILL COMBINING AMLODIPINE AND ATORVASTATIN OFFER GREATER LONG-TERM ADHERENCE BENEFIT OVER LOW-COST GENERIC 2-PILL CALCIUM CHANNEL BLOCKER/STATIN REGIMENS?
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)65499-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)65499-X/fulltext
Title :
PCV85 DOES A SINGLE PILL COMBINING AMLODIPINE AND ATORVASTATIN OFFER GREATER LONG-TERM ADHERENCE BENEFIT OVER LOW-COST GENERIC 2-PILL CALCIUM CHANNEL BLOCKER/STATIN REGIMENS?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65499-X&doi=10.1016/S1098-3015(10)65499-X
First page :
Section Title :
Open access? :
No
Section Order :
658